Juan C. Jaen, SVP, Drug Discovery & CSO at ChemoCentryx, Inc. (CCXI), sold 1,945 shares at $11.71 ($23K) on 2013-02-15, disclosed to the SEC on 2013-02-19.
Scheduled sale ($23k) by SVP, Drug Discovery & CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.71 | 1,245 | $15K | 63.9% |
| 2 | $11.78 | 700 | $8K | 36.1% |
| Total | $11.74 avg | 1,945 | $23K | 100% |
| Filing → |
| RCUS | SELL | 2026-01-07 | $681K | — | Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-12-05 | $4.1M | — | Filing → |